Nanomedicine for the Treatment of Lungs Cancer Its Challenges and Future Perspective-A Review

Abstract

A major public health concern with a global reach,lungs cancer necessitates cutting-edge techniques to treatment. Nanomedicine is a new technology that is currently being used to treat and diagnose lung cancer. This review examines the difficulties in using nano medicine to treat lung cancer and shows the promising directions for this rapidly developing field of study. The issues raised in this review cover a wide range of topics, such as medication delivery, targeted precision, toxicity, and legal obstacles. Approaches based on nanomedicine have the potential to get through these barriers thanks to improvements in drug delivery to lung cancer cell, a decrease in side effects, and increased therapeutic effectiveness. Additionally, this study explores the potential applications of nanomedicine for the treatment of lung cancer, highlighting the significance of cutting-edge technology including personalized medicine techniques,theranostic nanosystems, and targeted nanoparticles. These developments carry the possibility of individualized treatment plans, improved therapeutic results, and reduced side effects. Nanomedicine offers a multifaceted approach to address the challenges of lung cancer treatment, bringing new hope to patients and clinicians alike. By overcoming existing limitations and harnessing the potential of emerging technologies, nano medicine is poised to play a pivotal role in the future of lung cancer therapy. This review serves as a comprehensive overview of the field, shedding light on the path forward in the fight against lung cancer.